JPMorgan lowered the firm’s price target on Alkami (ALKT) to $38 from $40 and keeps an Overweight rating on the shares post the Q3 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALKT:
- Alkami Technology: Buy Rating Affirmed Amid Strong Fundamentals and Attractive Valuation
- Alkami price target lowered to $40 from $46 at Citizens JMP
- Alkami price target lowered to $25 from $30 at Barclays
- Alkami Technology Reports Strong Q3 2025 Results
- Alkami Technology Appoints New CFO Amid Strong Q3 Results